Article: Pharma’s response to COVID-19: What’s next?
Posted: 26 June 2020 | PerkinElmer | No comments yet
COVID-19 has affected nearly every Pharma industry. The development of a vaccine is challenging the world’s finest researchers and clinicians.
Clinical trials are underway to develop a vaccine and identify potential therapeutics, but management of the virus continues to bewilder the world’s finest researchers and clinicians. As a result, many of the social-distancing measures intended to prevent spread remain firmly in place, significantly altering the way life is lived and business is conducted.
Related content from this organisation
Related topics
Biopharmaceuticals, Disease research
Related organisations
PerkinElmer